Prospective multicentre study on antibiotic resistance of Helicobacter pylori strains obtained from children living in Europe
- 1 December 2006
- Vol. 55 (12) , 1711-1716
- https://doi.org/10.1136/gut.2006.091272
Abstract
To prospectively assess the antibacterial resistance rate in Helicobacter pylori strains obtained from symptomatic children in Europe. During a 4-year period, 17 paediatric centres from 14 European countries reported prospectively on patients infected with H pylori, for whom antibiotic susceptibility was tested. A total of 1233 patients were reported from Northern (3%), Western (70%), Eastern (9%) and Southern Europe (18%); 41% originated from outside Europe as indicated by mother's birth-country; 13% were 11 years of age. Testing was carried out before the first treatment (group A, n = 1037), and after treatment failure (group B, n = 196). Overall resistance to clarithromycin was detected in 24% (mean, A: 20%, B: 42%). The primary clarithromycin resistance rate was higher in boys (odds ratio (OR) 1.58; 1.12 to 2.24, p = 0.01), in children 12 years (OR 1.82, 1.10 to 3.03, p = 0.020) and in patients living in Southern Europe compared with those living in Northern Europe (OR 2.25; 1.52 to 3.30, p<0.001). Overall resistance rate to metronidazole was 25% (A: 23%, B: 35%) and higher in children born outside Europe (A: adjusted. OR 2.42, 95% CI: 1.61 to 3.66, p<0.001). Resistance to both antibiotics occurred in 6.9% (A: 5.3%, B: 15.3%). Resistance to amoxicillin was exceptional (0.6%). Children with peptic ulcer disease (80/1180, 6.8%) were older than patients without ulcer (p = 0.001). The primary resistance rate of H pylori strains obtained from unselected children in Europe is high. The use of antibiotics for other indications seems to be the major risk factor for development of primary resistance.Keywords
This publication has 25 references indexed in Scilit:
- Antimicrobial Resistance Incidence and Risk Factors amongHelicobacter pylori–Infected Persons, United StatesEmerging Infectious Diseases, 2004
- Basis for the Management of Drug-Resistant Helicobacter pylori InfectionDrugs, 2004
- The Relationship among Previous Antimicrobial Use, Antimicrobial Resistance, and Treatment Outcomes for Helicobacter pylori InfectionsAnnals of Internal Medicine, 2003
- Review article: the treatment of refractory Helicobacter pylori infectionAlimentary Pharmacology & Therapeutics, 2003
- Evaluation of a novel monoclonal enzyme immunoassay for detection of Helicobacter pylori antigen in stool from childrenGut, 2003
- Helicobacter pylori in Children and Adolescents: Increase of Primary Clarithromycin Resistance, 1997–2000Journal of Pediatric Gastroenterology and Nutrition, 2003
- Clarithromycin Resistance among Helicobacter pylori Strains Isolated from Children: Prevalence and Study of Mechanism of Resistance by PCR-Restriction Fragment Length Polymorphism AnalysisJournal of Clinical Microbiology, 2003
- Antibiotic susceptibility of Helicobacter pylori in Germany: stable primary resistance from 1995 to 2000Journal of Medical Microbiology, 2002
- Twelve year observation of primary and secondary antibiotic-resistant Helicobacter pylori strains in childrenThe Pediatric Infectious Disease Journal, 2001
- Clarithromycin as monotherapy for eradication of Helicobacter pylori: a randomized, double-blind trial.1993